Lipid signaling from beta cells can potentiate an inflammatory macrophage polarization
(University of Alabama at Birmingham) The insulin-producing beta cells in the pancreas unwittingly produce a signal that may aid their own demise in Type 1 diabetes, according to a study of the lipid signals that drive macrophage cells in the body to two different phenotypes of activated immune cells. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 21, 2020 Category: International Medicine & Public Health Source Type: news

Glycemic Control in T2DM Worse With Refusal of Insulin Therapy
THURSDAY, Feb. 20, 2020 -- For individuals with uncontrolled type 2 diabetes, those who decline insulin therapy have worse glycemic control, according to a study published online Feb. 20 in Diabetic Medicine. Alexander Turchin, M.D., from Brigham... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 20, 2020 Category: Pharmaceuticals Source Type: news

Patients frequently refuse insulin therapy, delaying blood sugar control
(Brigham and Women's Hospital) Investigators from Brigham and Women's Hospital find that more than 40% of patients refuse a physician's recommendation of insulin therapy. The study also finds that patients who decline insulin therapy had worse blood sugar control and it took them significantly longer to lower their blood sugar levels than patients who began insulin therapy. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 20, 2020 Category: International Medicine & Public Health Source Type: news

Prescription Medications Can Be Found on Craigslist
WEDNESDAY, Feb. 19, 2020 -- Prescription medications, especially analog insulin, can be found on Craigslist, according to a research letter published online Feb. 17 in JAMA Internal Medicine. Akram Ahamed, from the University of Delaware in Newark,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 19, 2020 Category: Pharmaceuticals Source Type: news

Insulet Brings in 2 Big Partnerships with CGM Powerhouses Abbott and DexCom
Insulet has snared two partnerships that will help it continue its strong momentum in the continuous glucose monitoring (CGM) market. The Billerica, MA-based company and one of the 25 most attractive medtech firms on the M&A radar, announced it had signed agreements with both Abbott Laboratories and DexCom. The agreements center around Insulet’s Omnipod Horizon Automated Insulin Delivery (AID) System, which is in pivotal trials in the U.S. The Omnipod Horizon System will be integrated with Abbott’s Freestyle Libre 2, which has approval in Europe. The Freestyle Libre 2 has not yet rec...
Source: MDDI - February 19, 2020 Category: Medical Devices Authors: Omar Ford Tags: Digital Health Business Source Type: news

Abbott and Insulet Partner to Integrate Next-Generation Glucose Sensing and Automated Insulin Delivery Technologies for Seamless Diabetes Care
Collaboration will combine Abbott's leading continuous glucose monitoring (CGM) technology with Insulet's Omnipod Horizon™ Automated Insulin Delivery System to offer an accurate, easy-to-use, integrated digital health platform Integrated technology will... Devices, Monitoring, Drug Delivery, Endocrinology Abbott, Insulet , Omnipod Horizon, diabetes (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 19, 2020 Category: Pharmaceuticals Source Type: news

Abbott and Insulet Partner to Integrate Next-Generation Glucose Sensing and Automated Insulin Delivery Technologies for Seamless Diabetes Care
- Collaboration will combine Abbott's leading continuous glucose monitoring (CGM) technology with Insulet's Omnipod Horizon ™ Automated Insulin Delivery System to offer an accurate, easy-to-use, integrated digital health platform (Source: Abbott.com)
Source: Abbott.com - February 19, 2020 Category: Pharmaceuticals Source Type: news

Why Human Factors Terminology Needs Updating
Conclusion IEC 62366-1 leaves a chasm between Normal Use and Abnormal Use, so manufacturers might not consider some user actions to be “Use Errors” if these actions do not fit the IEC 62366-1 definition of use. In other words, Use Errors may go undetected, unaddressed, or unmitigated. To protect users and manufacturers, this gap must be closed: IEC 62366-1 should be updated to address user actions that do not fit the current definitions of Normal Use nor Abnormal Use. To mend this gap in IEC 62366-1, we suggest to: Re-define Abnormal Use in terms of abuse. Remove Normal Use. Remove the &...
Source: MDDI - February 19, 2020 Category: Medical Devices Authors: Kaivon Assani Tags: Design Source Type: news

The list of insurers covering Senseonics ’ diabetes device is growing. The latest? Cigna.
Germantown ’s Senseonics Holdings Inc. has just added global insurance giant Cigna Corp. to the roster of payers covering its blood-sugar sensor system for diabetes patients. Cigna’s coverage of the local medical device company’s implantable continuous glucose monitoring (CGM) system called Eversense — which detects glucose levels to inform whether insulin, food or exercise is needed — became effective Feb. 15, Senseonics (NYSE: SENS) announced Tuesday. The Connecticut insurer is one of… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - February 18, 2020 Category: Biotechnology Authors: Sara Gilgore Source Type: news

Price Hike Lead Patients to Craigslist for Insulin
A new study found that hundreds of ads were placed on Craigslist for insulin and asthma inhalers during a 12-day period in June 2019. (Source: WebMD Health)
Source: WebMD Health - February 18, 2020 Category: Consumer Health News Source Type: news

High Price of Insulin, Albuterol Leads Some to Craigslist High Price of Insulin, Albuterol Leads Some to Craigslist
The unregulated sale and purchase of prescription medication isare prohibited by law and by Craigslist policy, but this doesn't seem to deter some people.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 18, 2020 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news

Price Hikes Have Patients Turning to Craigslist for Insulin, Asthma Inhalers
TUESDAY, Feb. 18, 2020 -- Maybe you've gone to Craigslist to find a used car or a secondhand couch, but imagine having to turn to the internet to pay for lifesaving drugs. It's already happening: A new study found that hundreds of ads were placed... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - February 18, 2020 Category: General Medicine Source Type: news

Price Hikes Have Patients Turning to Craigslist for Insulin, Asthma Inhalers
Title: Price Hikes Have Patients Turning to Craigslist for Insulin, Asthma InhalersCategory: Health NewsCreated: 2/18/2020 12:00:00 AMLast Editorial Review: 2/18/2020 12:00:00 AM (Source: MedicineNet Diabetes General)
Source: MedicineNet Diabetes General - February 18, 2020 Category: Endocrinology Source Type: news

Unregulated sales of insulin common on Craigslist
(Reuters Health) - Unregulated and deeply discounted sales of insulin are common on Craigslist, a new study finds. (Source: Reuters: Health)
Source: Reuters: Health - February 17, 2020 Category: Consumer Health News Tags: healthNews Source Type: news

Sitting more is associated with higher heart disease risk in older women
(American Heart Association) Post-menopausal Hispanic women sat an average of about 8-1/2 hours per day, compared to more than 9 hours per day for non-Hispanic women.In the total sample of older women, prolonged sitting time patterns were associated with significantly greater body mass index, waist circumference, fasting blood sugar, insulin, triglycerides and insulin resistance. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 17, 2020 Category: International Medicine & Public Health Source Type: news

Medtronic Faces Class I Recall Over Insulin Pumps
Medtronic is facing a Class I recall from FDA for the MiniMed Insulin Pump. The recall was issued on February 12 and one death and 2,175 injuries are connected to the technology. Medtronic told MD+DI in an email it proactively notified customers in November of 2019 about a potential issue with MiniMed 600 series insulin pumps. The Dublin-based company’s pumps faced the recall because of a missing or broken retainer ring that helps lock the insulin cartridge into place. Medtronic said if the reservoir is not properly locked into the pump, it could lead to over or under delivery of insulin, whic...
Source: MDDI - February 14, 2020 Category: Medical Devices Authors: Omar Ford Tags: Regulatory and Compliance Source Type: news

Medtronic MiniMed 600 Series Insulin Pumps Recalled
FRIDAY, Feb. 14, 2020 -- More than 322,000 MiniMed 600 Series Insulin Pumps have been recalled by Medtronic due to a defect that could cause them to malfunction and put users at risk for serious harm or death. The recalled devices lack or have a... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 14, 2020 Category: Pharmaceuticals Source Type: news

Health Highlights: Feb. 14, 2020
Here are some of the latest health and medical news developments, compiled by the editors of HealthDay: Medtronic MiniMed 600 Series Insulin Pumps Recalled More than 322,000 MiniMed 600 Series Insulin Pumps have been recalled by Medtronic due to a... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - February 14, 2020 Category: General Medicine Source Type: news

Medtronic MiniMed 600 Series Insulin Pumps Recalled
Title: Medtronic MiniMed 600 Series Insulin Pumps RecalledCategory: Health NewsCreated: 2/14/2020 12:00:00 AMLast Editorial Review: 2/14/2020 12:00:00 AM (Source: MedicineNet Diabetes General)
Source: MedicineNet Diabetes General - February 14, 2020 Category: Endocrinology Source Type: news

FDA Issues MiniMed600 Insulin Pump Recall FDA Issues MiniMed600 Insulin Pump Recall
If the pumps in question, models 630G and 670G, have broken or missing retainer rings, a potentially loose insulin cartridge could lead to incorrect dosing and possibly hyperglycemia or hypoglycemia.News Alerts (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - February 13, 2020 Category: Drugs & Pharmacology Tags: Diabetes & Endocrinology News Alert Source Type: news

322,000 Insulin Pumps Recalled After Injuries, 1 Death Reported
(CNN) — Medtronic has recalled some of its insulin pumps after injuries and one death were reported due to the device malfunctioning, according to a US Food and Drug Administration announcement on Wednesday. The FDA identified it as a Class I recall, the most serious type of recall. Insulin pumps are small devices that can deliver insulin and help diabetes patients reach desired blood glucose levels as part of their management of the disease. Medtronic has recalled certain MiniMed 600 Series insulin pumps for delivering incorrect insulin dosing due to a missing or broken retainer ring, which helps lock the insulin ca...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - February 13, 2020 Category: Consumer Health News Authors: Health – CBS Boston Tags: Consumer Health News Syndicated CBSN Boston CNN Diabetes Source Type: news

Medtronic recalls MiniMed insulin pumps after one death
FDA says the insulin pumps can deliver the wrong amount of insulin, a potentially serious health hazard. (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - February 13, 2020 Category: Consumer Health News Source Type: news

Medtronic recalling some MiniMed insulin pumps
Medtronic's "artificial pancreas" is the subject of a recall notice after it was discovered that a part of the device can be damaged, causing the device to malfunction. The FDA declared the recall of Medtronic's MiniMed 600 series insulin pumps a Class I recall on Wednesday, its most serious classification. The 600 series includes the Model 630G and the Model 670G. Over 26,000 people have complained about the device, the FDA said. Medtronic is aware of 2,175 po ssible injuries due to device malfunction,… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - February 13, 2020 Category: Biotechnology Authors: Carrigan Miller Source Type: news

Medtronic recalls certain MiniMed insulin pumps tied to 1 death
Medtronic has recalled some of its insulin pumps after injuries and one death were reported due to the device malfunctioning, according to a US Food and Drug Administration announcement on Wednesday. (Source: CNN.com - Health)
Source: CNN.com - Health - February 12, 2020 Category: Consumer Health News Source Type: news

A missing or broken retainer ring could cause under or over delivery of insulin. This may cause patient injury or death. Find out more about the recall. https://go.usa.gov/xd59C  
A missing or broken retainer ring could cause under or over delivery of insulin. This may cause patient injury or death. Find out more about the recall. https://go.usa.gov/xd59C  (Source: Food and Drug Adminstration (FDA): CDRHNew)
Source: Food and Drug Adminstration (FDA): CDRHNew - February 12, 2020 Category: Medical Devices Authors: ( at FDADeviceInfo) Source Type: news

Today, the @US_FDA identified a Class I Recall, the most serious type of recall: Medtronic Recalls MiniMed Insulin Pumps for incorrect insulin dosing.pic.twitter.com/qcg5tFiznt
Today, the @US_FDA identified a Class I Recall, the most serious type of recall: Medtronic Recalls MiniMed Insulin Pumps for incorrect insulin dosing. pic.twitter.com/qcg5tFiznt (Source: Food and Drug Adminstration (FDA): CDRHNew)
Source: Food and Drug Adminstration (FDA): CDRHNew - February 12, 2020 Category: Medical Devices Authors: ( at FDADeviceInfo) Source Type: news

Drug Duo Speeds Regeneration of Key Cells Lost in Diabetes
WEDNESDAY, Feb. 12, 2020 -- A novel combination of two drugs appeared to spur faster regeneration of insulin-producing beta cells in the pancreas, a preliminary study in mice and human tissue found. Beta cells are crucial to making insulin, a... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - February 12, 2020 Category: General Medicine Source Type: news

HCV Eradication With DAA Improves Insulin Resistance HCV Eradication With DAA Improves Insulin Resistance
This study aimed to assess whether SVR after direct-acting antivirals could improve the degree of insulin resistance in HCV-infected patients, including those with cirrhosis.Journal of Viral Hepatitis (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 11, 2020 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Blood glucose levels may be managed using smart insulin patch
According to a study published inNature Biomedical Engineering, a smart insulin patch that monitors blood glucose levels may be able to effectively deliver insulin to people with diabetes.Medical Dialogues (Source: Society for Endocrinology)
Source: Society for Endocrinology - February 6, 2020 Category: Endocrinology Source Type: news

Largest ever evaluation of the cardiovascular risk of rosiglitazone published
Analysis of raw individual patient level data gives more accurate picture of drug ’s link to heart problems Related items fromOnMedica People on statins at greater risk of skin infections and diabetes Adding insulin to metformin linked to higher mortality Vitamin D does not reduce kidney damage in type 2 diabetes Raised risk of MI and mortality when starting sulfonylurea Use of DPP-4 inhibitors associated with increased risk of IBD (Source: OnMedica Latest News)
Source: OnMedica Latest News - February 6, 2020 Category: UK Health Source Type: news

Negotiated Prices, Formulary Could Cut Medicare Rx Spending
WEDNESDAY, Feb. 5, 2020 -- Using negotiated prices and a defined formulary, similar to the Department of Veterans Affairs (VA), Medicare could save billions of dollars on prescription insulin for patients with diabetes, according to a research... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 5, 2020 Category: Pharmaceuticals Source Type: news

Negotiating Insulin Costs Could Save U.S. Billions
The researchers said that if Medicare were allowed to negotiate drug prices like the U.S. Department of Veterans Affairs (VA) can, Medicare could save about $4.4 billion just on insulin. (Source: WebMD Health)
Source: WebMD Health - February 4, 2020 Category: Consumer Health News Source Type: news

Medicare Could Save Billions If Allowed to Negotiate Insulin Prices
TUESDAY, Feb. 4, 2020 -- If you don't need insulin, you probably haven't paid much attention to its skyrocketing cost, but new research shows that exorbitant drug pricing eventually affects everyone. The study found that in 2017, Medicare spent... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - February 4, 2020 Category: General Medicine Source Type: news

Medicare Could Save Billions If Allowed to Negotiate Insulin Prices
Title: Medicare Could Save Billions If Allowed to Negotiate Insulin PricesCategory: Health NewsCreated: 2/4/2020 12:00:00 AMLast Editorial Review: 2/4/2020 12:00:00 AM (Source: MedicineNet Diabetes General)
Source: MedicineNet Diabetes General - February 4, 2020 Category: Endocrinology Source Type: news

Researchers successfully test coin-sized smart insulin patch, potential diabetes treatment
(University of North Carolina Health Care) The study, published in Nature Biomedical Engineering, describes research conducted on mice and pigs. The research team, led by Zhen Gu, Ph.D., professor of bioengineering at the UCLA Samueli School of Engineering, is applying for FDA approval of clinical trials in humans. Gu and colleagues conducted the initial successful tests of the smart insulin patch in mice in 2015 as part of the UNC/NC State Joint Department of Biomedical Engineering. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 4, 2020 Category: International Medicine & Public Health Source Type: news

Type 1 diabetes could be tackled by injecting insulin-producing cells into the eye 
In a new trial, patients will have donor cells injected into the anterior chamber - the fluid-filled space between the iris (the coloured part of the eye) and the inner surface of the cornea at the front. (Source: the Mail online | Health)
Source: the Mail online | Health - February 4, 2020 Category: Consumer Health News Source Type: news

First Approval for Fast-Acting Lispro for Diabetes; EU OKs Oral Semaglutide First Approval for Fast-Acting Lispro for Diabetes; EU OKs Oral Semaglutide
EMA panel recommends approval of oral GLP-1 agonist semaglutide for type 2 diabetes. It has also given the thumbs up to a mealtime, or fast-acting form, of insulin lispro for adults with diabetes.International Approvals (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - January 31, 2020 Category: Drugs & Pharmacology Tags: Diabetes & Endocrinology News Alert Source Type: news

Study: Tasting no-calorie sweetener may affect insulin response on glucose tolerance test
(University of Illinois at Urbana-Champaign, News Bureau) New research led by University of Illinois professor of food science and human nutrition M. Yanina Pepino, left, suggests that just tasting something sweet, such as the artificial sweetener sucralose, may affect individuals' responses on glucose tolerance tests. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 31, 2020 Category: International Medicine & Public Health Source Type: news

Human Insulin Is Available For As Little As $24.88 - But It ’s Not For Everyone
Human insulin is different from synthetic insulin, and one is significantly cheaper. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - January 30, 2020 Category: Pharmaceuticals Authors: John LaMattina, Contributor Source Type: news

Type 2 diabetes: The dangerous symptom that affects this body part
TYPE 2 diabetes is a condition that causes the level of sugar i the blood to become too high, caused by problems with the body's level of insulin. Spotting the early warning signs of the condition is crucial and there is a dangerous symptom found in this body part. What is it? (Source: Daily Express - Health)
Source: Daily Express - Health - January 30, 2020 Category: Consumer Health News Source Type: news

CVS offers option for diabetes drugs with no out-of-pocket cost
CVS Health Corp said on Wednesday it is launching a prescription drug coverage plan in which patients would have no out-of-pocket costs for insulin and other expensive diabetes treatments. (Source: Reuters: Health)
Source: Reuters: Health - January 29, 2020 Category: Consumer Health News Tags: healthNews Source Type: news

I Just Bought A Vial Of Human Insulin For $24.88
Human insulin is different from synthetic insulin, and one is significantly cheaper. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - January 29, 2020 Category: Pharmaceuticals Authors: John LaMattina, Contributor Source Type: news

Lilly plans donation of 200,000 insulin KwikPens over next three years to support lower-income communities
Insulin donation, along with $2 million in grants to relief agencies, extends program launched in 2018 INDIANAPOLIS, Jan. 28, 2020 -- (Healthcare Sales & Marketing Network) -- Starting this month, Eli Lilly and Company (NYSE: LLY) will donate at least ... Biopharmaceuticals, Drug Delivery, Endocrinology Eli Lilly, KwikPen, insulin, Humalog, diabetes (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 28, 2020 Category: Pharmaceuticals Source Type: news

Illinois Law Caps Insulin Patient Costs at $100 Monthly Illinois Law Caps Insulin Patient Costs at $100 Monthly
On Friday, the governor of Illinois signed a law capping monthly insulin costs at $100 for people covered by state-regulated commercial health insurance plans.Associated Press (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 27, 2020 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news

Type 2 diabetes: Having this problem with your feet could mean you’re at risk
TYPE 2 diabetes is a serious problem and a worldwide health epidemic. The condition is where the insulin the pancreas makes can't work properly and noticing this symptom in your feet could be a warning that you may be at risk. What is it? (Source: Daily Express - Health)
Source: Daily Express - Health - January 27, 2020 Category: Consumer Health News Source Type: news

High Insulin Prices May Be First Remedy For New Blue Cross Drug Maker
The new subsidiary of nonprofit generic drug maker Civica Rx and backed by Blue Cross and Blue Shield plans is poised to go after prescriptions that are generic yet have little competition and high prices like insulin. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - January 24, 2020 Category: Pharmaceuticals Authors: Bruce Japsen, Contributor Source Type: news

Insulin Resistance (Symptoms, Causes, Diagnosis, Treatment, and Reversal))
Title: Insulin Resistance (Symptoms, Causes, Diagnosis, Treatment, and Reversal))Category: Diseases and ConditionsCreated: 2/10/2004 12:00:00 AMLast Editorial Review: 1/24/2020 12:00:00 AM (Source: MedicineNet Diabetes General)
Source: MedicineNet Diabetes General - January 24, 2020 Category: Endocrinology Source Type: news

What Will It Take to Lower the Cost of Insulin in the US? What Will It Take to Lower the Cost of Insulin in the US?
Mayo Clinic hematologist S. Vincent Rajkumar breaks down the complexity of the problem and outlines potential solutions.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - January 22, 2020 Category: Drugs & Pharmacology Tags: Diabetes & Endocrinology News Source Type: news

Vitamin D supplementation linked to potential improvements in blood pressure in children
(University of Pittsburgh) Overweight and obese vitamin D-deficient children who took a relatively high dose of vitamin D every day for six months had lower blood pressure and improved insulin sensitivity than their peers who took a lower dose. The study did not show improvements in other markers of cardiovascular and metabolic health, a finding that indicates vitamin D supplementation alone may not be the cure-all for children at highest risk for diabetes and heart disease. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 21, 2020 Category: International Medicine & Public Health Source Type: news

Medtech in a Minute: Bigfoot Has Friends in High Places, DexCom Shines at JPM, and More
Bigfoot Gets by with a Little Help from Its Friends Bigfoot Biomedical is on track to submit its diabetes technology for FDA clearance this year, and the product could hit the market by year end. It helps that the company has some friends with deep pockets like Abbott and other investors that kicked in a total of $45 million in an initial tranche of a series C financing. Bigfoot's injection-based digitized insulin dosing platform uses a connected insulin pen-based system that integrates Abbott’s FreeStyle Libre glucose sensing technology.   DexCom Gives JPM ...
Source: MDDI - January 18, 2020 Category: Medical Devices Authors: Amanda Pedersen Tags: Business Source Type: news